News

ORIC Pharmaceuticals Announces Key Participation in Investor Events

ORIC Pharmaceuticals Announces Key Participation in Investor Events

Upcoming Investor Conference Participation by ORIC Pharmaceuticals

In an exciting development for investors and stakeholders, ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC), a forward-thinking clinical stage oncology company, is set to participate in several significant investor events this coming November. These conferences offer a valuable platform for the company to engage with the investment community, share insights, and discuss its innovative approaches to overcoming therapeutic resistance in cancer treatment.

Guggenheim's 2nd Annual Healthcare Innovation Conference

Taking place on a prominent stage, the management team from ORIC Pharmaceuticals will participate in a fireside chat at Guggenheim's 2nd Annual Healthcare Innovation Conference. On November 11, buy-side and sell-side analysts along with healthcare professionals can expect to gain insights at 1:30 p.m. ET. This engaging forum is an excellent opportunity for both industry veterans and new entrants to uncover the latest trends in oncology.

Stifel 2025 Healthcare Conference

On November 12, ORIC will also partake in one-on-one meetings at the Stifel 2025 Healthcare Conference. These personalized discussions will allow the management team to connect directly with potential investors, discuss company strategies, and delve deeper into the unique challenges the company is addressing with their groundbreaking drug candidates.

Jefferies London Healthcare Conference

Lastly, ORIC Pharmaceuticals will be represented at the Jefferies London Healthcare Conference on November 19, participating in a fireside chat at 2:30 p.m. GMT. This international presence not only highlights ORIC's commitment to transparency but also its ambition to showcase their critical work across borders and to a global audience, emphasizing the impact of their clinical trials and innovations.

Webcasts and Replay Availability

For those unable to attend these conferences in person, ORIC will provide webcasts of the fireside chat discussions. These can be accessed through the investor relations section of ORIC's official website. It’s noteworthy that replays will remain available for 90 days after each event, ensuring that investors and interested parties can catch up on essential insights and information shared during these important discussions.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is dedicated to enhancing patient outcomes by focusing on mechanisms of resistance to cancer therapies. Their lead product candidates include ORIC-944, an allosteric inhibitor targeting the polycomb repressive complex 2 (PRC2), aimed at treating prostate cancer, and enozertinib (ORIC-114), which is a brain-penetrant inhibitor targeting specific EGFR and HER2 mutations across various genetically defined cancers. With headquarters in both South San Francisco and San Diego, ORIC strives to lead innovations in oncology.

Contact Information

For further inquiries, interested parties can contact Dominic Piscitelli, the Chief Financial Officer of ORIC Pharmaceuticals, via email at dominic.piscitelli@oricpharma.com. Alternatively, general inquiries can be directed to info@oricpharma.com.

Frequently Asked Questions

What is ORIC Pharmaceuticals focused on?

ORIC Pharmaceuticals is focused on developing innovative treatments that address the mechanisms of therapeutic resistance in cancer.

When is ORIC participating in the upcoming investor conferences?

ORIC Pharmaceuticals will participate in various investor conferences throughout November, including events hosted by Guggenheim, Stifel, and Jefferies.

How can investors access the webcasts of the conferences?

Investors can access webcasts of the fireside chats through the investor relations section on ORIC's official website, with replays available for 90 days.

What are ORIC's lead product candidates?

ORIC's main product candidates are ORIC-944, targeting prostate cancer, and enozertinib (ORIC-114), aimed at multiple genetically defined cancers.

Who can I contact for more information regarding ORIC Pharmaceuticals?

Dominic Piscitelli, the Chief Financial Officer, is the main contact person, and inquiries can be sent to his email or the general info email at ORIC.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 13

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 4

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 1

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 1

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 4

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni Federal Advances Cybersecurity with JCHK Selection

Updated Category News Views 209

Omni Federal Joins the U.S. Cyber Command's JCHK Initiative Omni Federal is thrilled to share its recent selection for the Joint Cyber Hunt Kit (JCHK) competition. This significant achievement is managed through the Defense Innovation Unit (DIU), representing a major advancement in enhancing military and national security cyber capabilities. The collaboration establishes...

Continue Reading
Innovative AI Imaging Solutions Unveiled by Leopard Imaging

Updated Category News Views 159

Leopard Imaging Teams Up with Sony to Transform Imaging Technology Leopard Imaging Inc. is at the forefront of intelligent vision solutions, pushing boundaries with its latest collaboration with Sony Semiconductor Solutions Corporation. Together, they are set to unveil the GS500 AI Vision System, a remarkable advancement in imaging technology, specially designed for smart...

Continue Reading
Understanding the Shift in Lennox International's Stock Sentiment

Updated Category News Views 206

Overview of Lennox International's Short Interest Lennox International (NYSE: LII) has seen a notable decrease in its short percent of float, with a recent report indicating a 19.92% drop. Currently, approximately 1.07 million shares are sold short, representing about 3.78% of all regular shares available for trading. Traders should note that based on the current trading...

Continue Reading
Experience Autumn Fun with FIND THE HALLOWEEN SHIBUYA on Roblox

Updated Category News Views 169

FIND THE HALLOWEEN SHIBUYA Launches on Roblox In an exciting development for gaming and community engagement, transcosmos inc. and Future Design Shibuya have come together to unveil "FIND THE HALLOWEEN SHIBUYA," a captivating game on Roblox. This initiative seeks to enhance Shibuya's charm and promote good manners among players. By immersing users in a Halloween-themed...

Continue Reading
Metro Diner Launches Exciting New Location in Evansville

Updated Category News Views 287

Metro Diner Opens Its Doors in Evansville Metro Diner, a brand celebrated for its unique take on classic American comfort food, has proudly established its first location in Evansville. The new diner can be found at 945 N. Burkhardt Road, nestled in the vibrant Lillian Plaza. This 3,600-square-foot establishment is led by experienced Managing Partner Chris Wyatt, who is...

Continue Reading